Xuejing Zou

914 total citations
26 papers, 672 citations indexed

About

Xuejing Zou is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Xuejing Zou has authored 26 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Xuejing Zou's work include Cancer, Hypoxia, and Metabolism (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and RNA modifications and cancer (5 papers). Xuejing Zou is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and RNA modifications and cancer (5 papers). Xuejing Zou collaborates with scholars based in China and United States. Xuejing Zou's co-authors include Dehua Wu, Li Liu, Ling Lei, Dongyan Zhang, Liwei Xie, Xiaolong Qi, Chuanhui Cao, Yang Song, Ling Deng and Xiao Hu and has published in prestigious journals such as Advanced Functional Materials, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Xuejing Zou

24 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuejing Zou China 12 504 407 61 57 56 26 672
Xuan Zhu China 15 339 0.7× 273 0.7× 91 1.5× 29 0.5× 43 0.8× 28 519
Pan Liu China 15 354 0.7× 233 0.6× 105 1.7× 18 0.3× 55 1.0× 32 554
Jian Pu China 15 608 1.2× 476 1.2× 72 1.2× 30 0.5× 72 1.3× 43 744
Liansheng Gong China 14 306 0.6× 235 0.6× 112 1.8× 16 0.3× 54 1.0× 29 519
Minhua Wu China 16 547 1.1× 389 1.0× 160 2.6× 30 0.5× 87 1.6× 47 785
Shou‐Mei Wang China 11 294 0.6× 135 0.3× 47 0.8× 55 1.0× 58 1.0× 16 415
Manar Atyah China 13 287 0.6× 204 0.5× 135 2.2× 18 0.3× 117 2.1× 27 543
Tianwei Chen China 11 247 0.5× 133 0.3× 87 1.4× 17 0.3× 53 0.9× 25 421
Tasneem Motiwala United States 17 662 1.3× 209 0.5× 148 2.4× 22 0.4× 63 1.1× 21 865

Countries citing papers authored by Xuejing Zou

Since Specialization
Citations

This map shows the geographic impact of Xuejing Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejing Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejing Zou more than expected).

Fields of papers citing papers by Xuejing Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuejing Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejing Zou. The network helps show where Xuejing Zou may publish in the future.

Co-authorship network of co-authors of Xuejing Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Xuejing Zou. A scholar is included among the top collaborators of Xuejing Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuejing Zou. Xuejing Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Chengjie, et al.. (2025). An Endoplasmic Reticulum‐Targeting and Calcium Metabolism‐Disrupting Nanodrug Enhances Tumor Photodynamic Immunotherapy. Advanced Functional Materials. 35(32). 2 indexed citations
2.
Xiao, Lushan, Lin Zeng, Chang Hong, et al.. (2025). Development and Validation of Machine Learning‐Based Marker for Early Detection and Prognosis Stratification of Nonalcoholic Fatty Liver Disease. Advanced Science. 12(33). e10527–e10527. 2 indexed citations
3.
Hong, Chang, Hao Cui, Yan Li, et al.. (2025). Association between red blood cell indices and non-alcoholic fatty liver disease: Prospective study and two-sample Mendelian randomization analysis based on large cohorts. Annals of Hepatology. 30(2). 101775–101775. 2 indexed citations
4.
Chang, Hong, Liang Shen, Hao Cui, et al.. (2025). Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine. Journal of Translational Medicine. 23(1). 769–769.
5.
Xiao, Lushan, Yan Li, Hong Chang, et al.. (2024). Polygenic risk score of metabolic dysfunction-associated steatotic liver disease amplifies the health impact on severe liver disease and metabolism-related outcomes. Journal of Translational Medicine. 22(1). 650–650. 7 indexed citations
6.
Chang, Hong, Hao Cui, Jie Peng, et al.. (2022). Predictive Value of the Hepatic Immune Predictive Index for Patients with Primary Liver Cancer Treated with Immune Checkpoint Inhibitors. Digestive Diseases. 41(3). 422–430. 3 indexed citations
7.
8.
Liu, Shanshan, Guangchuang Yu, Li Liu, et al.. (2021). Identification of Prognostic Stromal-Immune Score–Based Genes in Hepatocellular Carcinoma Microenvironment. Frontiers in Genetics. 12. 625236–625236. 4 indexed citations
9.
Zhang, Dongyan, Xuejing Zou, Yang Song, et al.. (2020). Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2. Journal of Experimental & Clinical Cancer Research. 39(1). 229–229. 27 indexed citations
10.
Song, Yang, Hui Wang, Xuejing Zou, et al.. (2020). Reciprocal regulation of HIF-1α and Uroplakin 1A promotes glycolysis and proliferation in Hepatocellular Carcinoma. Journal of Cancer. 11(22). 6737–6747. 5 indexed citations
11.
Qian, Long, et al.. (2019). PFKFB3/HIF-1α feedback loop modulates sorafenib resistance in hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications. 513(3). 642–650. 33 indexed citations
12.
Zou, Xuejing, et al.. (2019). The TCP1 ring complex is associated with malignancy and poor prognosis in hepatocellular carcinoma.. PubMed. 12(9). 3329–3343. 29 indexed citations
13.
14.
Zhang, Dongyan, Xuejing Zou, Chuanhui Cao, et al.. (2018). Identification and Functional Characterization of Long Non-coding RNA MIR22HG as a Tumor Suppressor for Hepatocellular Carcinoma. Theranostics. 8(14). 3751–3765. 75 indexed citations
15.
16.
Zou, Xuejing, et al.. (2016). Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway. Journal of Pharmacological Sciences. 131(4). 233–240. 77 indexed citations
17.
18.
Xiao, Lushan, Xuejing Zou, Wei Hu, & Li Liu. (2016). [Expression of microRNA-107 in hepatocellular carcinoma and its clinical significance].. PubMed. 36(7). 974–8. 1 indexed citations
19.
Gao, Juan, Zhenshun Song, Xia Lin, et al.. (2007). Deregulated expression of Notch receptors in human hepatocellular carcinoma. Digestive and Liver Disease. 40(2). 114–121. 69 indexed citations
20.
Zou, Xuejing, et al.. (1988). Effects of praeruptorin C and E isolated from ‘Qian-Hu’ on swine coronary artery and guinea-pig atria. European Journal of Pharmacology. 155(3). 293–296. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuan Zhu Breakdown of academic impact, for papers by Pan Liu Breakdown of academic impact, for papers by Jian Pu Breakdown of academic impact, for papers by Liansheng Gong Breakdown of academic impact, for papers by Minhua Wu Breakdown of academic impact, for papers by Shou‐Mei Wang Breakdown of academic impact, for papers by Manar Atyah Breakdown of academic impact, for papers by Tianwei Chen Breakdown of academic impact, for papers by Tasneem Motiwala
Rankless by CCL
2026